{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:42:37Z","timestamp":1787010157893,"version":"build-2736575974"},"reference-count":57,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"18","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81571973"],"award-info":[{"award-number":["81571973"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81772165"],"award-info":[{"award-number":["81772165"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the NSFC-NIH Biomedical collaborative research program","award":["81761128001"],"award-info":[{"award-number":["81761128001"]}]},{"name":"the National 13th Five-Year Grand Program on Key Infectious Disease Control","award":["2017ZX10202102-005-003"],"award-info":[{"award-number":["2017ZX10202102-005-003"]}]},{"name":"the National 13th Five-Year Grand Program on Key Infectious Disease Control","award":["2017ZX10202101-004-001"],"award-info":[{"award-number":["2017ZX10202101-004-001"]}]},{"name":"the Beijing Municipal of Science and Technology Major Project","award":["D161100000416003"],"award-info":[{"award-number":["D161100000416003"]}]},{"name":"the Beijing Municipal of Science and Technology Major Project","award":["Z161100000516148"],"award-info":[{"award-number":["Z161100000516148"]}]},{"name":"the Beijing Key Laboratory for HIV\/AIDS Research","award":["BZ0089"],"award-info":[{"award-number":["BZ0089"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Individuals infected with hepatitis B virus (HBV) are often coinfected with human immunodeficiency virus (HIV). However, individuals with chronic HBV infection living with acute HIV infection have a significantly lower HBV viral load, along with higher HBeAg and HBsAg loss than HBV-infected individuals alone. Here, we investigated the possible role of natural killer cells (NK cell) function in this progressive course to explore the relationship between phenotypic\/functional changes in NK cells during acute HIV infection and HBV clearance in patients with HIV\/HBV coinfection.<\/jats:p>\n                    <jats:p>Peripheral blood NK cells from 38 patients with primary HIV infection, including 20 with untreated HIV infection and 18 treatment-na\u00efve patients with HIV\/HBV coinfection and 16 patients with chronic HBV infection, were enrolled in this study.<\/jats:p>\n                    <jats:p>\n                      We found that the HIV\/HBV-coinfected individuals had higher levels of NK cells than the HBV-infected individuals, due to expansion of the CD56\n                      <jats:sup>neg<\/jats:sup>\n                      NK cell population. The proportion of NK cells in CD56\n                      <jats:sup>dim<\/jats:sup>\n                      and CD56\n                      <jats:sup>bri<\/jats:sup>\n                      NK subsets was not found significant difference between HIV\/HBV-coinfected and HBV-infected individuals. However, NKG2C levels on NK cells and subsets were significantly higher in HIV\/HBV-coinfected individuals than in HBV-infected individuals, whereas NKG2A levels were unaffected or decreased. In addition, the levels of degranulation CD107a, cytotoxicity and IFN-\u03b3 production of NK cells were increased in HIV\/HBV-coinfected individuals than in HBV-infected individuals. The level of IL-10 production of NK cells was decreased in HIV\/HBV-coinfected individuals than in HBV-infected individuals. Furthermore, the level of HBV-DNA was inversely correlated with the proportion of NKG2C\n                      <jats:sup>+<\/jats:sup>\n                      and NKG2C\n                      <jats:sup>+<\/jats:sup>\n                      NKG2A\n                      <jats:sup>\u2212<\/jats:sup>\n                      NK cells, while positively correlated with the proportion of NKG2A\n                      <jats:sup>+<\/jats:sup>\n                      and NKG2C\n                      <jats:sup>-<\/jats:sup>\n                      NKG2A\n                      <jats:sup>+<\/jats:sup>\n                      NK cells. IFN-\u03b3 production was inversely correlated with levels of HBV-DNA, but the CD107a expression and IL-10 production of NK cells were not correlated with HBV-DNA levels.\n                    <\/jats:p>\n                    <jats:p>These results demonstrate that the upregulation of NKG2C expression, but not of NKG2A expression on the surface of NK cells increases cytolytic capacity and the amounts of cytokines produced and may play a crucial role in HBV clearance during HIV\/HBV-coinfection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000020073","type":"journal-article","created":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T23:35:02Z","timestamp":1588376102000},"page":"e20073","source":"Crossref","is-referenced-by-count":4,"title":["NKG2C+ natural killer cell function improves the control of HBV replication in individuals with acute HIV infection coinfected with HBV"],"prefix":"10.1097","volume":"99","author":[{"given":"Ting","family":"Song","sequence":"first","affiliation":[{"name":"Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University"},{"name":"Beijing Key Laboratory for HIV\/AIDS Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[{"name":"Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University"},{"name":"Beijing Key Laboratory for HIV\/AIDS Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Su","sequence":"additional","affiliation":[{"name":"Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University"},{"name":"Beijing Key Laboratory for HIV\/AIDS Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifeng","family":"Liu","sequence":"additional","affiliation":[{"name":"Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University"},{"name":"Beijing Key Laboratory for HIV\/AIDS Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[{"name":"Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University"},{"name":"Beijing Key Laboratory for HIV\/AIDS Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Yang","sequence":"additional","affiliation":[{"name":"Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University"},{"name":"Beijing Key Laboratory for HIV\/AIDS Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyue","family":"Zhang","sequence":"additional","affiliation":[{"name":"Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University"},{"name":"Beijing Key Laboratory for HIV\/AIDS Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Guo","sequence":"additional","affiliation":[{"name":"Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University"},{"name":"Beijing Key Laboratory for HIV\/AIDS Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University"},{"name":"Beijing Key Laboratory for HIV\/AIDS Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guizhen","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Beijing Youan hospital, Capital Medical University, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[{"name":"Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University"},{"name":"Beijing Key Laboratory for HIV\/AIDS Research"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,5]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1365-2893.2003.00487.x","article-title":"Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures","volume":"11","author":"Lavanchy","year":"2004","journal-title":"J Viral Hepat"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2009.11.009","article-title":"Epidemiology of hepatitis B and C viruses: a global overview","volume":"14","author":"Te","year":"2010","journal-title":"Clin Liver Dis"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S2468-1253(18)30056-6","article-title":"Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study","volume":"3","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/01.aids.0000163936.99401.fe","article-title":"Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort","volume":"19","author":"Konopnicki","year":"2005","journal-title":"AIDS"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1097\/QAD.0000000000001574","article-title":"HIV-hepatitis B virus coinfection: epidemiology, pathogenesis, and treatment","volume":"31","author":"Singh","year":"2017","journal-title":"AIDS"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1097\/QAD.0000000000001646","article-title":"Hepatitis B, hepatitis C, and mortality among HIV-positive individuals","volume":"31","author":"Thornton","year":"2017","journal-title":"AIDS"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/rmv.1956","article-title":"Hepatitis in AIDS patients","volume":"28","author":"Qadir","year":"2018","journal-title":"Rev Med Virol"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/cid\/ciu710","article-title":"Acute HIV infection is beneficial for controlling chronic hepatitis B","volume":"60","author":"Jiao","year":"2015","journal-title":"Clin Infect Dis"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"2","DOI":"10.20411\/pai.v3i1.228","article-title":"ADCC-mediated CD56(DIM) NK cell responses are associated with early HBsAg clearance in acute HBV infection","volume":"3","author":"Yu","year":"2018","journal-title":"Pathog Immun"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/gut.2008.163600","article-title":"Early kinetics of innate and adaptive immune responses during hepatitis B virus infection","volume":"58","author":"Fisicaro","year":"2009","journal-title":"Gut"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1053\/j.gastro.2012.10.039","article-title":"Blocking the natural killer cell inhibitory receptor NKG2A increases activity of human natural killer cells and clears hepatitis B virus infection in mice","volume":"144","author":"Li","year":"2013","journal-title":"Gastroenterology"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1084\/jem.20121172","article-title":"Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion","volume":"210","author":"Peppa","year":"2013","journal-title":"J Exp Med"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"S765","DOI":"10.1093\/infdis\/jix356","article-title":"Immunopathogenesis of hepatitis B virus","volume":"216","author":"Tseng","year":"2017","journal-title":"J Infect Dis"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.4049\/jimmunol.1601313","article-title":"T Cells infiltrating diseased liver express ligands for the NKG2D stress surveillance system","volume":"198","author":"Huang","year":"2017","journal-title":"J Immunol"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12977-016-0271-z","article-title":"NK cells control HIV-1 infection of macrophages through soluble factors and cellular contacts in the human decidua","volume":"13","author":"Quillay","year":"2016","journal-title":"Retrovirology"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.3389\/fimmu.2018.02290","article-title":"NK Cells in HIV-1 Infection: From Basic Science to Vaccine Strategies","volume":"9","author":"Florez-Alvarez","year":"2018","journal-title":"Front Immunol"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.3389\/fimmu.2017.01176","article-title":"NKG2C(+)NKG2A(-) natural killer cells are associated with a lower viral set point and may predict disease progression in individuals with primary HIV infection","volume":"8","author":"Ma","year":"2017","journal-title":"Front Immunol"},{"key":"R18-20230915","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1086\/513878","article-title":"Evolution of innate and adaptive effector cell functions during acute HIV-1 infection","volume":"195","author":"Alter","year":"2007","journal-title":"J Infect Dis"},{"issue":"(Suppl 3)","key":"R19-20230915","doi-asserted-by":"crossref","first-page":"S377","DOI":"10.1086\/655971","article-title":"Cohorts for the study of HIV-1-exposed but uninfected individuals: benefits and limitations","volume":"202","author":"Horton","year":"2010","journal-title":"J Infect Dis"},{"key":"R20-20230915","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3389\/fimmu.2017.00470","article-title":"Altered natural killer cell function in HIV-exposed uninfected infants","volume":"8","author":"Smith","year":"2017","journal-title":"Front Immunol"},{"key":"R21-20230915","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.it.2014.11.001","article-title":"NK cells regulating T cell responses: mechanisms and outcome","volume":"36","author":"Crouse","year":"2015","journal-title":"Trends Immunol"},{"key":"R22-20230915","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1046\/j.1440-1711.2002.01063.x","article-title":"Hepatoimmunology: a perspective","volume":"80","author":"Mackay","year":"2002","journal-title":"Immunol Cell Biol"},{"key":"R23-20230915","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1182\/blood-2005-03-1100","article-title":"Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection","volume":"106","author":"Alter","year":"2005","journal-title":"Blood"},{"key":"R24-20230915","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3389\/fimmu.2014.00390","article-title":"NK cell subset redistribution during the course of viral infections","volume":"5","author":"Lugli","year":"2014","journal-title":"Front Immunol"},{"key":"R25-20230915","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.it.2010.08.003","article-title":"CD56 negative NK cells: origin, function, and role in chronic viral disease","volume":"31","author":"Bjorkstrom","year":"2010","journal-title":"Trends Immunol"},{"key":"R26-20230915","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2004-05-2058","article-title":"Imprint of human cytomegalovirus infection on the NK cell receptor repertoire","volume":"104","author":"Guma","year":"2004","journal-title":"Blood"},{"key":"R27-20230915","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1086\/509811","article-title":"The contribution of cytomegalovirus to changes in NK cell receptor expression in HIV-1-infected individuals","volume":"195","author":"Mela","year":"2007","journal-title":"J Infect Dis"},{"key":"R28-20230915","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1038\/cti.2017.22","article-title":"NKG2C(+) memory-like NK cells contribute to the control of HIV viremia during primary infection: Optiprim-ANRS 147","volume":"6","author":"Gondois-Rey","year":"2017","journal-title":"Clin Transl Immunology"},{"key":"R29-20230915","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3851\/IMP2953","article-title":"Upregulation of NKG2C+ natural killer cells, TLR-2 expression on monocytes and downregulation of regulatory T-cells influence PEG-IFN treatment efficacy in entecavir-suppressed patients with CHB","volume":"20","author":"Yan","year":"2015","journal-title":"Antivir Ther"},{"key":"R30-20230915","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/imm.13039","article-title":"Conserved and variable NK cell receptors: diverse approaches to viral infections","volume":"156","author":"Bastidas-Legarda","year":"2019","journal-title":"Immunology"},{"key":"R31-20230915","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev.immunol.16.1.359","article-title":"NK cell receptors","volume":"16","author":"Lanier","year":"1998","journal-title":"Annu Rev Immunol"},{"key":"R32-20230915","doi-asserted-by":"crossref","first-page":"5199","DOI":"10.1073\/pnas.95.9.5199","article-title":"HLA-E is a major ligand for the natural killer inhibitory receptor CD94\/NKG2A","volume":"95","author":"Lee","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R33-20230915","doi-asserted-by":"crossref","first-page":"e0135874","DOI":"10.1371\/journal.pone.0135874","article-title":"Natural Killer p46 controls hepatitis B virus replication and modulates liver inflammation","volume":"10","author":"Li","year":"2015","journal-title":"PLoS One"},{"key":"R34-20230915","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1093\/infdis\/jiy097","article-title":"Increased NK cell function after cessation of long-term Nucleos(t)ide analogue treatment in chronic hepatitis B is associated with liver damage and HBsAg loss","volume":"217","author":"Zimmer","year":"2018","journal-title":"J Infect Dis"},{"key":"R35-20230915","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11908-017-0588-3","article-title":"Primary HIV infection: clinical presentation, testing, and treatment","volume":"19","author":"Henn","year":"2017","journal-title":"Curr Infect Dis Rep"},{"key":"R36-20230915","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/QAD.0b013e3283328d1f","article-title":"Chronic HIV-1 viremia reverses NKG2A\/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection","volume":"24","author":"Brunetta","year":"2010","journal-title":"AIDS"},{"key":"R37-20230915","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jhep.2018.10.006","article-title":"NK-cell responses are biased towards CD16-mediated effector functions in chronic hepatitis B virus infection","volume":"70","author":"Schuch","year":"2019","journal-title":"J Hepatol"},{"key":"R38-20230915","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/infdis\/jit561","article-title":"Compromised function of natural killer cells in acute and chronic viral hepatitis","volume":"209","author":"Lunemann","year":"2014","journal-title":"J Infect Dis"},{"key":"R39-20230915","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3389\/fimmu.2014.00222","article-title":"Higher expression of activating receptors on cytotoxic NK cells is associated with early control on HIV-1C multiplication","volume":"5","author":"Kulkarni","year":"2014","journal-title":"Front Immunol"},{"key":"R40-20230915","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1097\/01.aids.0000183632.12418.33","article-title":"Switch from inhibitory to activating NKG2 receptor expression in HIV-1 infection: lack of reversion with highly active antiretroviral therapy","volume":"19","author":"Mela","year":"2005","journal-title":"AIDS"},{"key":"R41-20230915","doi-asserted-by":"crossref","first-page":"e0160171","DOI":"10.1371\/journal.pone.0160171","article-title":"Altered immune profiles of natural killer cells in chronic hepatitis B patients: a systematic review and meta-analysis","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"key":"R42-20230915","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1136\/gutjnl-2017-314098","article-title":"Regulatory NK cells mediated between immunosuppressive monocytes and dysfunctional T cells in chronic HBV infection","volume":"67","author":"Li","year":"2018","journal-title":"Gut"},{"key":"R43-20230915","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s11427-018-9407-2","article-title":"NK cells in liver homeostasis and viral hepatitis","volume":"61","author":"Peng","year":"2018","journal-title":"Sci China Life Sci"},{"key":"R44-20230915","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fimmu.2013.00057","article-title":"NK cells: a double-edged sword in chronic hepatitis B virus infection","volume":"4","author":"Maini","year":"2013","journal-title":"Front Immunol"},{"key":"R45-20230915","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.3748\/wjg.v25.i27.3527","article-title":"Immune suppression in chronic hepatitis B infection associated liver disease: a review","volume":"25","author":"Li","year":"2019","journal-title":"World J Gastroenterol"},{"key":"R46-20230915","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/jvh.12299","article-title":"Circulating CD56dim natural killer cells and CD56+ T cells that produce interferon-gamma or interleukin-10 are expanded in asymptomatic, E antigen-negative patients with persistent hepatitis B virus infection","volume":"22","author":"Conroy","year":"2015","journal-title":"J Viral Hepat"},{"key":"R47-20230915","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1146\/annurev.immunol.19.1.65","article-title":"Noncytolytic control of viral infections by the innate and adaptive immune response","volume":"19","author":"Guidotti","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"R48-20230915","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41598-017-00387-2","article-title":"Natural killer cell activation contributes to hepatitis B viral control in a mouse model","volume":"7","author":"Tong","year":"2017","journal-title":"Sci Rep"},{"key":"R49-20230915","doi-asserted-by":"crossref","first-page":"e86927","DOI":"10.1371\/journal.pone.0086927","article-title":"Decreased peripheral natural killer cells activity in the immune activated stage of chronic hepatitis B","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"R50-20230915","doi-asserted-by":"crossref","first-page":"e1001227","DOI":"10.1371\/journal.ppat.1001227","article-title":"Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection","volume":"6","author":"Peppa","year":"2010","journal-title":"PLoS Pathog"},{"key":"R51-20230915","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jhep.2018.10.006","article-title":"NK-cell responses are biased towards CD16-mediated effector functions in chronic hepatitis B virus infection","volume":"70","author":"Schuch","year":"2018","journal-title":"J Hepatol"},{"key":"R52-20230915","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3389\/fimmu.2012.00351","article-title":"Natural killer cell functional dichotomy: a feature of chronic viral hepatitis?","volume":"3","author":"Mondelli","year":"2012","journal-title":"Front Immunol"},{"key":"R53-20230915","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/QAI.0b013e3181aa256e","article-title":"Elevated natural killer cell activity despite altered functional and phenotypic profile in Ugandans with HIV-1 clade A or clade D infection","volume":"51","author":"Eller","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R54-20230915","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jhep.2009.12.015","article-title":"A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B","volume":"52","author":"Tan","year":"2010","journal-title":"J Hepatol"},{"key":"R55-20230915","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3389\/fimmu.2014.00258","article-title":"The role of natural killer cells and CD8(+) T cells in hepatitis B virus infection","volume":"5","author":"Schuch","year":"2014","journal-title":"Front Immunol"},{"key":"R56-20230915","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.23977","article-title":"Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients","volume":"53","author":"Zhang","year":"2011","journal-title":"Hepatology"},{"key":"R57-20230915","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1111\/jvh.12946","article-title":"CD56(bright) natural killer cells induce HBsAg reduction via cytolysis and cccDNA decay in long-term entecavir-treated patients switching to peginterferon alfa-2a","volume":"25","author":"Shi","year":"2018","journal-title":"J Viral Hepat"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000020073","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T18:56:57Z","timestamp":1694804217000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000020073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":57,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000020073","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5]]}}}